Conclusions: Ischemic heart disease is the leading cause of death in the 90 days following total joint replacement, and there is an increase in postoperative deaths associated with digestive system-related disease following joint replacement. Interventions targeted at reducing these diseases may have the largest effect on mortality in total joint replacement patients.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence. P atients undergoing total hip or total knee replacement are selected according to their capacity to undergo major surgery. The highest-risk patients are excluded from joint-replacement surgery, which leads to a lower risk of death in joint-replacement patients than in the general age and sexmatched population [1] [2] [3] . However, undergoing surgery causes a short-term increase in the risk of death that then returns to baseline between 30 and 90 days following the operation [2] [3] [4] . Older patients and male patients have higher mortality rates 4, 5 , and cardiac disease and thromboembolic complications are major causes of short-term mortality 5, 6 . We wished to determine the major causes of short, medium, and long-term mortality in the joint-replacement population compared with individuals in an age and sex-matched population. We chose to look separately at hip and knee replacements to determine whether the results were similar for both procedures, a finding that would presumably reflect the increased risk associated with anesthesia and postoperative care rather than the nature of the intervention. These findings may help to identify patients at greatest risk of death following joint replacement, suggest potential preventative interventions, and enable clinicians and patients to consider the trade-off between the short-term increased perioperative risks and the longer-term benefits. . Joint-replacement patients with an untraceable National Health Service (NHS) number, withdrawn consent, or unknown age and/or sex (261 hips and 243 knees) as well as those undergoing simultaneous bilateral operations (6, Of the 91,422 patients who underwent hip replacement and 85,698 who underwent knee replacement with no associated HES identifier, 67,700 (74%) and 57,924 (68%), respectively, had their operation performed at an independent hospital or treatment center and 19,697 (22%) and 23,426 (27%), respectively, had their replacements performed in Wales. Among the remaining 4,025 hip-replacement patients (4%) and 4,348 knee-replacement patients (5%), 1,664 and 1,870, respectively, had their operation in December 2012. We could not ascertain the reason for missing HES numbers in the remainder.
Materials and Methods

Patients and Data Sources
We subdivided the main causes of death into 5 groups according to the first letter of the ICD-10 code: malignant neoplasms (C), circulatory system (I), *The values are given as the number of observed deaths, the number of expected deaths (obtained from national rates), and the resulting SMR, with the 95% CI in parentheses. †Linkage to the actual cause of death in the HES record was available only for these cases.
respiratory system (J), digestive system (K), and all others. Further, a priori subdivision was made of the deaths related to circulatory-system disorders into ischemic heart disease (ICD-10 codes I20 to I25), pulmonary heart disease and diseases of the pulmonary circulation (I26 to I28), and cerebrovascular disease (I60 to I69).
Statistics
Patients were divided into 4 age groups: <60, 60 to 69, 70 to 79, and ‡80 years at the time of the operation, and Kaplan-Meier curves were used to describe the cumulative mortality for men and women up to a maximum of 9.75 years following the operation. Cumulative incidence function curves were constructed for the defined competing causes of death; these function curves properly sum to total cumulative mortality. Cause of death was not known for 380 of the 26,766 deaths following hip replacement and for 484 of the 29,802 deaths following knee replacement; while the likely impact is small, arbitrarily these deaths have been grouped separately.
Observed and expected numbers of deaths were compared for the grouped causes of death given above. Expected numbers of deaths were calculated by obtaining age and sex-specific midyear populations and numbers of deaths for each cause for England and Wales from the Office for National Statistics for 2003 through 2012 8, 9 . These numbers were used to calculate age, sex, and cause-specific annual mortality rates. For each patient, we calculated the total times at risk within each age-band within each calendar year and calculated the patient's expected mortality risk by multiplying these values by the appropriate rates and summing them and then summing across patients. The standardized mortality ratios (SMRs) were calculated by dividing the observed number of deaths by the expected number of deaths, and the 95% confidence intervals (CIs) were calculated as well. Using cut-points of 90 days and 1, 3, 5, and 7 years, we further partitioned the follow-up periods into intervals of time following the primary operation, and we calculated SMRs for these intervals. Statistical analysis was performed with Stata version 13.1 (StataCorp).
Results
Hip Replacement
I n the study period, 33,759 of the 424,156 hip-replacement patients died; 332,734 patients had an HES identifier, enabling the cause of death to be determined in 26,766. The proportion of males in this final hip-replacement cohort was lower than in the patients without an HES identifier (40.4% compared with 42.8%; see Appendix), the patients were older (a median age of 70 years and an interquartile range [IQR] of 62 to 76 years compared with a median age of 69 years and an IQR of 61 to 76 years), and they had slightly greater all-cause cumulative mortality (a 5-year Kaplan-Meier estimated cumulative percentage mortality of 9.5% [95% CI, 9.4% to 9.7%] compared with 8.0% [95% CI, 7.8% to 8.2%]). Finally, all-cause SMR was slightly higher in the 332,734 included patients than in the whole cohort of 424,156 patients (0.61 [95% CI, 0.60 to 0.62] compared with 0.59 [95% CI, 0.58 to 0.60]) (Table I) .
Malignant neoplasms were the main cause of death in 9,037 cases (33.8%); circulatory disorders, in 8,784 (32.8%); respiratory disorders, in 2,928 (10.9%); and digestive disorders, in 1,465 (5.5%); 4,172 patients died of other causes, and the cause was unknown in 380 patients (Table I) .
Figures 1-A through 1-H show the cumulative incidences of competing risk of death by age and sex. In patients under the age of 60 years, males had a slightly higher cumulative risk of mortality driven by a higher rate of death due to circulatory system-related diseases (Figs. 1-A and 1-B). With increasing age, the relative risk of death for males increased markedly compared with those for women with cancer, respiratory system-related disease, and circulatory system-related disease (Figs. 1-C through 1-H).
The cohort showed a marked selection effect, with a 39% relative reduction in mortality (SMR, 0.61; 95% CI, 0.60 to 0.62) based on 26,766 observed and 43,976 expected deaths (Table I ). This effect was seen for all 5 categories of cause of death but had disappeared (the waning effect) by 7 years postoperatively for deaths from neoplasms, circulatory systemrelated causes, and digestive system-related causes. Respiratory system-related deaths and the group of deaths from all other causes both showed a persistent relative reduction in mortality, even at 7 to 10 years. For most causes, the SMR was timedependent. It was lowest in the period from 91 days to 1 year following the operation and then slowly rose. The overall SMR was 0.89 (95% CI, 0.86 to 0.93) at 7 to 10 years. 
Ischemic heart disease was the most common cause of death within 90 days (29% [431] of the deaths). The risk of death within 90 days following the operation was elevated compared with the 90-day to 1-year period in circulatory system-related, respiratory system-related, and digestive system-related disorders as well as all other causes of death. The group of patients who died from digestive system-related disorders showed a 30% relative increased mortality (SMR, 1.30; 95% CI, 1.09 to 1.53) compared with the general population. The ICD-10 codes associated with the most deaths were duodenal ulcer (K26), vascular disorders of intestine (K55), paralytic ileus and intestinal obstruction without hernia (K56), and diverticular disease of the intestine (K57), with the first 3 categories almost certainly reflecting postoperative complications (see Appendix). Malignant neoplasms had an SMR of 0.19 (95% CI, 0.16 to 0.23) that rose to 0.52 (95% CI, 0.49 to 0.55) in the 90-day to 1-year postoperative period.
A more detailed examination of circulatory systemrelated diseases showed markedly elevated risks within 90 days postoperatively for ischemic heart disease (I20 to I25), with 431 deaths (SMR 1.21; 95% CI, 1.10 to 1.33) (Table II) . Pulmonary heart disease, including pulmonary embolism (I26 to I28), was very rare, with only 20 deaths within 90 days postoperatively (SMR, 1.27; 95% CI, 0.78 to 1.97). There was no evidence of acute increased risk of death due to cerebrovascular disease (I60 to I69); its SMR (0.38; 95% CI, 0.30 to 0.47) did not differ within 90 days postoperatively compared with the 91-day to 1-year postoperative period. Cumulative all-cause mortality shown separately for men (blue) and women (red) up to 9.75 years after the primary hip replacement, with cumulative incidence rates for competing risk of death from malignant neoplasms (malig neo), circulatory system-related disorders (circ syst), respiratory system-related disorders (resp syst), digestive system-related disorders (dig syst), other causes, and unknown causes (cause NK). 568 (Table III) . The major causes of death were malignant neoplasms in 9,917 cases (33.3%); circulatory disorders, in 9,932 (33.3%); respiratory disorders, in 2,932 (9.8%); and digestive disorders, in 1,572 (5.3%); 4,965 patients died of other causes, and the cause of death was unknown in 484 (see Appendix).
The cumulative mortality risks for men and women by age group were similar, with men having greater mortality in all age groups (Figs. 2-A through 2-H) . There was evidence of relative excess mortality in males from malignant neoplasms, even in the youngest age group.
The selection effect of patients receiving a knee replacement was even stronger, with an overall 43% relative reduction in mortality (SMR, 0.57; 95% CI, 0.56 to 0.57) (Table III) . There was a residual reduction in SMRs for all 5 categories of causes of death except deaths due to digestive system diseases, even at 7 to 10 years of follow-up, although a similar waning effect was seen. Excess mortality in the immediate postoperative period was seen for circulatory system-related, respiratory system-related, and digestive system-related disorders as well as other causes of death compared with the 90-day to 569
1-year postoperative period. In the first 90 days after surgery 31% [436] of the deaths were due to ischemic heart disease.
There was a paucity of deaths from malignant neoplasms (SMR, 0.10; 95% CI, 0.08 to 0.12) in this period. The specific ICD codes with the highest number of deaths from digestive system disorders in the knee-replacement group were the same as those in the hip-replacement group (see Appendix). Examination of circulatory system-related deaths again found excess mortality from ischemic heart disease and pulmonary diseases in the immediate postoperative period compared with the 90-day to 1-year period (Table II) . Deaths due to pulmonary diseases, including pulmonary embolus, within 90 days following surgery (I26 to I28) were higher than expected in the general population (SMR, 1.55; 95% CI, 1.03 to 2.25).
Discussion W e observed a marked selection effect for mortality among patients receiving hip or knee replacement. This is due to the confounding effect of health status, which determines the likelihood of undergoing elective surgical intervention and subsequent mortality. This pattern is seen in nonoperative examples such as occupational cohorts in which the mortality risk of workers selected in certain jobs is lower than in the general population 10 , as well as studies of migrants, in which migrants in general show lower mortality than the population of origin because of either better health or higher socioeconomic status facilitating their ability to migrate 11, 12 . The clearest example of this marked selection is the low postoperative mortality for cancer-related deaths, as advanced cancer would usually be a *The values are given as the observed number of deaths, the expected number of deaths (obtained from national rates), and the resulting SMR, with the 95% CI in parentheses. †Linkage to the actual cause of death in the HES record was available only for these cases.
contraindication for joint replacement for the treatment of osteoarthritis. The waning effect is also recognized in the occupational literature; however, its interpretation is more complex, as a toxic work-related exposure may have long-term harms that negate beneficial selection. Assuming joint replacement does not increase mortality risk-for example, increased mobility following intervention leading to greater fall-related mortality-then the most likely explanation for this pattern is that the aging cohort of individuals may develop a comorbidity that would now prohibit them from having a joint-replacement procedure and hence they lose their selection advantage. In addition, the aging control population will include a greater proportion of healthy survivors as those with premature mortality die 13 . We observed a greater selection bias for patients undergoing knee replacement. Although the waning effect appeared slower, this probably reflects an improved baseline. Therefore, it merely takes more time before the knee-replacement cohort reaches the same mortality rate as the general population. This difference in selection is unlikely to be explained by differences in age or sex 14 , and it cannot be explained by differences in comorbidity profile or severity, as these are very similar between the hip and knee-replacement cohorts (see Appendix). A comparison of the social gradients of those receiving either a knee replacement or a hip replacement found a stronger inverse social gradient for hips than for knees; rates fell with higher area deprivation 15 . Paradoxically, this suggests more social selection for hip replacement than for knee replacement. However, that study did not examine provision in relation to the need for surgery. Another possibility is that patients and/or surgeons are more conservative in their desire for knee surgery, so that, given the same level of preoperative risk, patients with knee pain are less likely to undergo surgery.
The patterns of causes of death by age and sex are what one might expect from the mortality trends in the general population. Men have a greater mortality risk than women do in relation to cardiovascular disease, but at younger ages cancer mortality is a common cause of death relative to other causes. We expected to see an excess mortality from ischemic heart disease and thromboembolic complications in the immediate postoperative period. However, the elevated risk of death from digestive system-related disorders was unexpected. We suspect that a proportion of these deaths is attributable to postoperative complications, given the similarity in patterns for both procedures, and these deaths may be preventable through more assiduous patient selection or improved perioperative care. Clinicians should be aware of this risk and anticipate problems such as perforations, obstructions, and gastrointestinal bleeds. The routine use of preventative strategies such as antacids, proton pump inhibitors 16 , and preoperative carbohydrate drinks may reduce this increased risk of mortality secondary to digestive system-related disorders 17 . The common use of nonsteroidal anti-inflammatory drugs in patients with osteoarthritis may lead to an increased risk of cardiac and digestive system-related deaths in this population 18 .
Measures to decrease the risk of death from pulmonary embolus are now used routinely, and there is evidence that using both mechanical and chemical thromboprophylaxis is associated with decreased postoperative mortality 2, 3 . Despite the small numbers, we still found evidence of a modestly elevated risk. This may reflect some degree of undermanagement or cases in which an explicit decision was made not to use thromboprophylaxis Cumulative all-cause mortality shown separately for men (blue) and women (red) up to 9.75 years after primary knee replacement, with cumulative incidence rates for competing risk of death from malignant neoplasms (malig neo), circulatory system-related disorders (circ syst), respiratory system-related disorders (resp syst), digestive system-related disorders (dig syst), other causes, and unknown causes (cause NK). 572
because of contraindications. The only way to determine the cause of this elevated risk would be to undertake a confidential inquiry and perform root cause analysis. Ischemic heart disease is the greatest single cause of mortality for either procedure. Clinicians should focus their attention on preventing these deaths, thereby maximizing the added value of the surgical procedure. Joint replacement itself may be cardioprotective, and this may be due to increased capacity for physical activity and its beneficial effects against risk factors common for circulatory system-related deaths 18 . Strategies such as the routine use of low-dose aspirin in older males may be sensible [19] [20] [21] [22] as well as maximizing tertiary prevention strategies in patients with an established risk of cardiac complications. It is difficult to know what proportion of the approximately 3,500 deaths that occurred in the first year postoperatively could have been delayed given better medical care or preoperative screening.
It is well established that patients have a short-term elevation in the risk of mortality after hip and knee replacement. Lie et al. compared this elevated risk with that in the general population and identified an excess mortality of 0.12% lasting for 26 days 4 . We previously compared mortality in the postoperative period with that for patients on the waiting list for surgery in order to minimize the selection effect, and we found an excess mortality of 0.26% at 30 days for hip replacement 23 and 0.31% at 30 days for knee replacement 24 . The selection effect of decreased mortality in the longer term following arthroplasty has been described 1 , but the duration had not previously been established.
Berstock et al. noted that 6 of 7 studies reporting mortality rates after hip and knee arthroplasty found higher mortality rates after hip replacement, but the difference was not significant (p = 0.3 for both 30-day and 90-day postoperative mortality) 5 . Furthermore, they noted that 8 of 9 studies reporting the cause of death identified cardiovascular problems as the major cause. The marked increase in death from gastrointestinal causes was not shown, probably because previous studies were underpowered to identify this. A major strength of this analysis is the large size of the cohorts, which allowed us to look at the cause of death in greater detail over a long follow-up period and to make comparisons between the interventions. We were not able to link all NJR records, and there is some evidence that the patients whose records were not linked had lower mortality, which is consistent with the observation that a large proportion of these patients were managed in the independent sector and were presumably of higher socioeconomic status and had a lower mortality risk. We had to rely on the accuracy of death certification, which may have had errors. However, any such errors would apply to both cohorts as well as to the general-population control group. It is likely that deaths in the immediate postoperative period are better ascertained than deaths during other periods because of the need for a coroner's post-mortem examination. We cannot tell whether some of these events were potentially preventable, as this would require detailed note extraction.
Patients with the potential for postoperative complications relating to the digestive system should be identified preoperatively and may require more rigorous postoperative monitoring and management, including the use of prophylactic antacids, proton pump inhibitors, and preoperative carbohydrate drinks to avoid some of the increased risk of postoperative mortality due to digestive disorders. However, as ischemic heart disease remains the main cause of death after joint replacement, preventative strategies should target the patients whose cardiovascular risk could be lessened. This will not only increase life expectancy but enhance the cost-effectiveness of joint replacement.
